Clin Osteol 2008; 13(3): 97-101

Effect of hormonal contraception on bone mineral density and markers of bone metabolism in adolescentsOriginal contributions

M. Lattáková, M. Borovský, J. Payer, Z. Killinger

Background: An increase in bone mass is most rapid during puberty and it continues until approximately 20 to 25 years of age. Epi­ demiological studies of osteoporotic fractures suggest the importance of reaching peak bone mineral density during adolescence.

Patients and methods: The study comprised 69 healthy girls aged 16 to 19 years. At the start of the study and one year later, their bone mineral density in the proximal femur and lumbar spine was measured using the DXA scan and their serum osteocalcin and CTX levels were determined. Over the year, 32 girls were using contraception containing 30 pg of traception containing 15 pg of ethinylestradiol and 9 girls were included in a control group.

Results: Girls using contraception with 30 pg of ethinylestradiol increased their bone mineral density in the proximal femur by 0.88 %, those using contraception with 15 pg of ethinylestradiol by 0.78 % and the control gr re 0.82 %, 0.1 % and 0.56 %, respectively (insignificant changes between the groups).

Conclusions: Twelve-month use of low-dose and ultra-low-dose hormonal contra sity and markers of bone metabolism in 16- to 19-year-old adolescents

Keywords: oral contraception, bone mineral density, bone turnover, estrogens

Published: December 11, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lattáková M, Borovský M, Payer J, Killinger Z. Effect of hormonal contraception on bone mineral density and markers of bone metabolism in adolescents. Osteologický bulletin. 2008;13(3):97-101.
Download citation

References

  1. Compson JE. Sex steroids and bone. Physiol Rev 2001;81:419-447. Go to original source...
  2. Busen NH, Britt RB, Rianon N. Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years. J Health 2003;32:257-259. Go to original source...
  3. Burkman T. Oral contraceptives: Current status. Clin Ostet Gynecol 2001;44:62-72. Go to original source...
  4. Gordon CM. Bone density issues in adolescent gynecology patien lec Gynekol 2000;13:158. Go to original source...
  5. Sambrook P, Cooper C. Osteoporosis. Lancet 2006;367:2010-2018. Go to original source...
  6. Peterson B, Lee N. Long term health risks and benefits of oral contraceptive Obstet Gynecol Clin North Am 1990;17:775-788. Go to original source...
  7. Reed SD, Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Longitudi­ nal changes in bone density in relation to oral contraceptive use. Contraception 2003; 68:177-182. Go to original source...
  8. Gold AM, Bachrach LK. Contraceptive use in teens: A threat to bone health? J Adolesc Health 2004;35:427^29. Go to original source...
  9. Scholes D, LaCroixAZ, Ichikawa LE, Barlow WE, Ott SM. Change in bone mi­ neral density among adolescent women using and discontinuing depot medroxyp­ rogesterone acetate concentration. Arch Jfediatr AdolescMed 2005;2:139-144. Go to original source...
  10. World Health Organization. WHO statement on hormonal contraception and bone health. Weekly epidemiological record 2005;80:297-304.
  11. Bollen A, Martin H, Leroux B et al. Circadian variation in urinary excrection bone collagen cross-links. J Bone Miner Res 1995;10:1885-1890. Go to original source...
  12. Chiu KM, Ju J, Mayes D et al. Changes in bone resorption during the menstrual cycle. J Bone Miner Res 1999;14:609-615. Go to original source...
  13. Marowska J, Kobykinska M, Lukaszkiewicz J et al. Pyridium crosslinks of colla­ gen as a marker of bone resortion rate in chil and clinical application. Bone 1996;19:669-677 Go to original source...
  14. Nappi C, Di Spiezio Sardo A, Acunzo G et al. Effects of a low-dose and utra dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contracepti­ on 2003;67:355 - 359. Go to original source...
  15. Endricat J, Mih E, Duhsterberg B et al. A 3-year double blind, randomized, c trolled study on iffluence of two oral contraceptives containing either 20 pg or 30 pg ethinylestradiol in combination with levonorgestrel on bone mineral densi­ ty. Contraception 2004; 69:179-187. Go to original source...
  16. Sojáková M, Payer J, Borovský M, Killinger Z, Hrúziková P, Šteňová E, Ondr P. Kostná denzita vo vzťahu k užívaniu hormonálnej antikoncepcie. Osteologický Bulletin 2004;9:116-120.
  17. Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Ziegler J, Debanne SM. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral densi­ ty in a cohort of adolescent girls. J Adolesc Health 2004;35:434-441. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.